Ocular Genetic Diagnostic Market on Track for Strong Growth, Estimated to Grow at 9.4% CAGR Through 2029

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Ocular Genetic Diagnostic Market Through 2025?
The market size for ocular genetic diagnostics has seen robust growth in the past years. The projections show an increase from $0.98 billion in 2024 to $1.07 billion in 2025, marking a compound annual growth rate (CAGR) of 9.7%. Factors contributing to the significant increase during the historical period include the early adoption of molecular diagnostic procedures, heightened awareness of genetically inherited eye conditions, advancements in academic and clinical research, a rising occurrence of retinal dystrophies, and a heightened demand for pediatric genetic testing.

What's the Projected Size of the Global Ocular Genetic Diagnostic Market by 2029?
The market size of ocular genetic diagnostics is predicted to experience substantial growth in the ensuing years. It is projected to rise to $1.53 billion by 2029, displaying a compound annual growth rate (CAGR) of 9.4%. The surge during the forecast period can be credited to an increase in the need for tailor-made ophthalmic care, the enlargement of direct-to-consumer genetic examinations, amplified investment in gene therapy studies, the escalation of precision medicine initiatives, and the merging of artificial intelligence with genetic data interpretation. Key trends for the forecast period encompass the growing adoption of artificial intelligence-backed genetic investigation, the enlargement of genetic testing kits for home use, a rise in the necessity for prenatal ocular genetic screening, the creation of gene-specific diagnostic platforms, and progress in cloud-based genetic data storage.

View the full report here:
https://www.thebusinessresearchcompany.com/report/ocular-genetic-diagnostic-global-market-report

Top Growth Drivers in the Ocular Genetic Diagnostic Industry: What's Accelerating the Market?
The upward trend in ocular illnesses is anticipated to stimulate the expansion of the ocular genetic diagnostic field. These diseases incorporate a range of medical anomalies that could jeopardize vision or even cause blindness if not addressed promptly. This upswing in visual health concerns can be mainly attributed to amplified screen usage and digital device interaction, which can induce a host of vision complications such as eye fatigue and dry eyes. Ocular genetic diagnostic services aid the medical fraternity by identifying genetic markers at an early stage, assisting in understanding the origins of diseases more distinctly, and contributing to accurate diagnosis and treatment. In a case in point, a study conducted in February 2025 by the American Foundation for the Blind, an organization centered around individuals with vision impairment, showcased that out of adult Americans aged 18 and above, a total of 51.9 million reported facing some measure of visual issues. Of these, 3.7 million expressed substantial difficulty with vision even while using glasses, and 307,000 were totally blind, with the remaining 47.9 million disclosing minor vision problems despite the usage of glasses. Consequently, the intensifying surge of eye-related diseases is fuelling the development of the ocular genetic diagnostic industry.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28283&type=smp

What Trends Will Shape the Ocular Genetic Diagnostic Market Through 2029 and Beyond?
Prominent corporations in the ocular genetic diagnostic market are prioritizing the creation of innovative services, including clinical services, to improve early detection, diagnostic precision, and customized treatments for hereditary eye conditions. These services are healthcare activities conducted by professionals to assess, diagnose, and manage patients' health issues. For example, in October 2024, the Singapore National Eye Centre (SNEC), a specialty eye hospital in the public sector, introduced the Ocular Genetics Service (OGS), a clinical service designed to deliver specialized care for individuals with inherited eye diseases. This dedicated service consolidates genetic testing, counselling, and specific clinical management in one place, guaranteeing timely diagnosis and treatment for uncommon genetic eye conditions. By blending multidisciplinary expertise, the OGS improves diagnostic accuracy and allows patients to receive personalized care plans based on their genetic makeup. The launch of such clinical services signifies a wider shift in the ocular genetic diagnostics market towards precision medicine and comprehensive, patient-focused healthcare models.

What Are the Main Segments in the Ocular Genetic Diagnostic Market?
The ocular genetic diagnostic market covered in this report is segmented as

1) By Test Type: Single Gene Testing, Panel Testing, Whole Exome Sequencing, Whole Genome Sequencing
2) By Technology Type: Sequencing Technology, Polymerase Chain Reaction (PCR), Microarray Technology, Next-Generation Sequencing (NGS)
3) By Application: Retinal Disorders, Cataract Diagnosis, Inherited Ocular Disorders, Age-Related Macular Degeneration
4) By End User: Hospitals, Diagnostic Laboratories, Academic And Research Institutes, Other End Users

Subsegments:
1) By Single Gene Testing: Retinoblastoma Gene Testing (RB1), RPE65 Gene Mutation Testing, MYOC Gene Testing (Glaucoma), OPA1 Gene Testing (Optic Atrophy), BEST1 Gene Testing (Best Disease)
2) By Panel Testing: Inherited Retinal Disease (IRD) Panels, Glaucoma Genetic Panels, Macular Dystrophy Panels, Optic Neuropathy Panels, Syndromic Ocular Disorder Panels
3) By Whole Exome Sequencing (WES): Trio Exome Sequencing, Diagnostic Exome Sequencing, Exome Reanalysis Services, Rapid Exome Testing, Prenatal Exome Sequencing
4) By Whole Genome Sequencing (WGS): Clinical Whole Genome Sequencing, Rapid Whole Genome Sequencing, Pediatric Genome Sequencing, Prenatal Whole Genome Sequencing, Ultra-Rare Eye Disease Genome Sequencing

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=28283&type=smp

Which Top Companies are Driving Growth in the Ocular Genetic Diagnostic Market?
Major companies operating in the ocular genetic diagnostic market are Thermo Fisher Scientific Inc., Quest Diagnostics Inc., Illumina Inc., The Children's Hospital of Philadelphia, University of Iowa Hospitals and Clinics, PerkinElmer Inc., Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., ARUP Laboratories Inc., Invitae Corporation, Spark Therapeutics Inc., GeneDx LLC, Blueprint Genetics Oy, Medgenome Labs Inc., Centogene NV, PreventionGenetics LLC, Molecular Vision Laboratory LLC, Casey Eye Institute, and Moorfields Eye Hospital & UCL Institute of Ophthalmology.

Which Regions Will Dominate the Ocular Genetic Diagnostic Market Through 2029?
North America was the largest region in the ocular genetic diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in ocular genetic diagnostic report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=28283

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.